Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CleveXel Pharma S.A.S.
DescriptionPotassium channel KCa3.1 blocker
Molecular Target Potassium channel KCa3.1 (KCNN4)
Mechanism of ActionKCa3.1 potassium ion channel inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today